Titan Intech (521005)
TurnaroundScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹36.44 |
| Market Cap | ₹111 Cr |
| P/E Ratio | 12.97 |
| ROCE | 6.62% |
| ROE | 7.5% |
| Dividend Yield | 0% |
| Profit Growth | 56.13% |
| Debt/Equity | — |
| Sales Growth | 15.69% |
| 52-Week Range | ₹0.63 — ₹36.44 |
| Sector | IT - Services |
| Book Value | ₹0.99 |
Strengths
- Profit growth of 56.13% is far ahead of sales growth of 15.69%, showing margin expansion and operating leverage
- Latest quarter net margin is about 23% (₹3 Cr net profit on ₹13 Cr sales), indicating a sharp improvement in profitability
- Piotroski F-Score of 7/9 suggests the company's fundamentals are improving
- P/E of 12.97 and PEG of 0.36 are not demanding if the current growth proves sustainable
Concerns
- P/B of 36.81 against a book value of ₹0.99 means paying 36.8 times book for a business earning only 7.50% ROE
- ROCE of just 6.62% implies weak capital productivity and no clear competitive moat
- 52-week range of ₹0.63 to ₹36.44 shows a massive speculative price move, which raises risk of buying near a peak
- No dividend, no promoter holding data, and insufficient disclosure make governance and owner alignment unverifiable
AI Analysis
Let me start with what looks interesting. A P/E of 12.97 and a PEG of 0.36 are optically cheap if the growth is sustainable. Sales grew 15.69% while profit grew 56.13%, and the latest quarter shows ₹13 Cr of revenue producing ₹3 Cr of net profit, a roughly 23% margin. The Piotroski score of 7/9 also suggests the reported financial health is improving. But a value investor cannot fall in love with one quarter. At ₹36.44, I am paying 36.81 times book value for a business earning only 7.50% ROE and 6.62% ROCE. That is not a wonderful franchise. There is no visible moat in a small IT-enabled services company earning sub-8% returns on capital and offering zero dividend. More troubling is the 52-week range of ₹0.63 to ₹36.44. The stock has multiplied enormously in one year; in Indian microcaps, such moves often attract speculation rather than genuine compounding. Promoter holding is not disclosed, debt data is absent, and the FairStock Score is insufficient. Without these, I cannot underwrite governance or balance-sheet risk. This looks like a possible turnaround or special situation, not a proven compounder. I would put it on a watchlist and demand several quarters of consistent cash-backed profits before thinking of investing.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer